Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128832) titled 'A Clinical Study Evaluating the Safety, Tolerability, Biodistribution, Radiation Dosimetry and Preliminary Diagnostic Performance of 68Ga-TPP-FAPI in Patients with Malignant Tumours' on July 27.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Tianjin Cancer Hospital

Condition: malignant tumour

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-31

Target Sample Size: Intervention Group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=333718

Disclaimer: Curated by HT Syndication....